FindTrial
Sign In

Restylane Volyme

DEVICE6 trials

Sponsors

Galderma R&D, Erevna Innovations Inc., Chongqing Jinsaixing Medical Technology Co., Ltd

Conditions

Cheek AugmentationFacial Volume LossMidface Volume DeficitTemple HollowingVolume Deficiency of the Midfacethe Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Phase 4

Midfacial Product Selection
CompletedNCT03381040
Erevna Innovations Inc.Facial Volume Loss
Start: 2017-12-05End: 2019-01-08Updated: 2019-01-10

Unknown Phase

Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
CompletedNCT03289052
Galderma R&DMidface Volume Deficit
Start: 2017-12-01End: 2019-07-31Updated: 2023-05-12
A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers
CompletedNCT03869450
Galderma R&DVolume Deficiency of the Midface
Start: 2018-11-09End: 2019-08-30Updated: 2022-08-26
Study to Evaluate Satisfaction After Treatment With Restylane
CompletedNCT04638816
Galderma R&DCheek Augmentation
Start: 2021-04-16End: 2021-08-20Updated: 2024-03-06
Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing
RecruitingNCT06665477
Galderma R&DTemple Hollowing
Start: 2024-11-18End: 2026-07-31Target: 162Updated: 2025-01-17
The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
Active, not recruitingNCT07359079
Chongqing Jinsaixing Medical Technology Co., Ltdthe Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
Start: 2025-03-19End: 2027-02-27Updated: 2026-01-22